STOCK TITAN
  1. Home
  2. News
  3. NGMDF

NUGEN MED DEVICES INC - $NGMDF STOCK NEWS

Welcome to our dedicated page for NUGEN MED DEVICES news (Ticker: $NGMDF), a resource for investors and traders seeking the latest updates and insights on NUGEN MED DEVICES stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NUGEN MED DEVICES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NUGEN MED DEVICES's position in the market.

News
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement
Rhea-AI Summary
NuGen Medical Devices Inc. announces a debt settlement of €275,000 with Care4Pharma B.V. through the issuance of 2,000,000 common shares at $0.20 per share. The company also extends payment obligations under the Share Purchase Agreement, allowing repayment of €1,200,000 by November 8, 2026, with an additional payment of €275,000 due after a financing round of C$3,500,000. CEO Ian Heynen expresses satisfaction with the agreement, emphasizing strategic growth opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
News
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand
Rhea-AI Summary
NuGen Medical Devices Inc. announces that Sol-Millennium Medical Inc.'s global sales & marketing team has completed in-depth clinical training of NuGen's needle-free InsuJet™ medical device for sales and marketing throughout Europe. The training aims to facilitate sales in the diabetic markets in France and Spain. European order forecasts are expected soon, with first orders arriving before the end of Q1 2024. The company anticipates a positive relationship with Sol-M, with plans to go to market with the co-branded InsuJet™ needle-free medical device and consumables in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru
Rhea-AI Summary
NuGen Medical Devices Inc. reports that its distribution partner in Mexico, Science-Link Trading SAPI de CV, has expanded their distribution network to include Argentina, Chile, Costa Rica, and Peru. Science-Link is now partnering with a large family-owned laboratory and clinic conglomerate which is expected to see Science-Link expand its operations into big box retail pharmacies in Mexico. The company expects to exceed the target of 5,000 needle-free injectors and consumables in 2024. The estimated adult diabetic population in Mexico grew to 14 million patients in 2021, with 1 in 6 adults now living with diabetes. Diabetes-related health expenditure in Mexico has reached USD $20 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium
Rhea-AI Summary
NuGen Medical Devices Inc. (TSXV: NGMD) announces Verrue Consulting Group BV as an official distributor for its needle-free InsuJet™ device in Belgium, with estimated sales of $2.4 million and a gross margin of 72% over a 5-year term.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.
Rhea-AI Summary
NuGen Medical Devices Inc. (TSXV: NGMD) announced a 5-year exclusive distribution agreement with Advance Medical Life Co. Ltd. for its needle-free InsuJet™ device in Thailand, targeting initial sales to approximately 250,000 patients with Type 1 diabetes and estimating $4.9 million in sales if target sales of 29,000 devices over 5 years are met, with a gross margin of 72%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.43%
Tags
none
-
News
InsuJet(TM) Registered as a Medical Device in Mexico
Rhea-AI Summary
NuGen Medical Devices Inc. (TSXV: NGMD) announces the completion of the registration of its needle-free InsuJet™ injection device for sale throughout Mexico as a medical device. The Mexican government has paid in full the purchase order for 500 units of InsuJet™ devices from Science-Link Trading SAPI de CV. NuGen also reports a distribution agreement with Science-Link targeting the sale of approximately 5,000 needle-free injectors in 2024, with an estimated lifetime value of US$6.2M to 2027. Mexico's large diabetes market presents a significant opportunity for the company's product.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
NuGen Announces Closing of First Tranche of Private Placement of Units
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
NuGen M.D. Announces the Departure of its President and CEO and Immediate Appointment of New Interim Chief Executive Officer and Interim Chief Customer Officer
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News
NuGen M.D. Announces the Launch of its InsuJet(TM) Needle-Free Injection Device in Canada
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
NuGen M.D. Receives Approval for its Netherlands Site to Manufacture Needle-Free Devices Under ISO 13485 QMS Certificate
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Stock NGMDF logo
NUGEN MED DEVICES INC

OTC:NGMDF

NGMDF Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

NGMDF Stock Data

18.30M
182.58M
7.91%
Medical Devices
Healthcare
Link
United States of America
Toronto